| Literature DB >> 30578106 |
Daniel Duran1, Xue Zeng2, Sheng Chih Jin3, Jungmin Choi3, Carol Nelson-Williams2, Bogdan Yatsula4, Jonathan Gaillard1, Charuta Gavankar Furey1, Qiongshi Lu5, Andrew T Timberlake2, Weilai Dong2, Michelle A Sorscher6, Erin Loring2, Jennifer Klein7, August Allocco1, Ava Hunt1, Sierra Conine1, Jason K Karimy1, Mark W Youngblood8, Jinwei Zhang9, Michael L DiLuna1, Charles C Matouk1, Shrikant Mane10, Irina R Tikhonova10, Christopher Castaldi10, Francesc López-Giráldez10, James Knight10, Shozeb Haider11, Mariya Soban12, Seth L Alper13, Masaki Komiyama14, Andrew F Ducruet15, Joseph M Zabramski15, Alan Dardik4, Brian P Walcott16, Christopher J Stapleton17, Beverly Aagaard-Kienitz18, Georges Rodesch19, Eric Jackson20, Edward R Smith21, Darren B Orbach22, Alejandro Berenstein6, Kaya Bilguvar23, Miikka Vikkula24, Murat Gunel8, Richard P Lifton3, Kristopher T Kahle25.
Abstract
Normal vascular development includes the formation and specification of arteries, veins, and intervening capillaries. Vein of Galen malformations (VOGMs) are among the most common and severe neonatal brain arterio-venous malformations, shunting arterial blood into the brain's deep venous system through aberrant direct connections. Exome sequencing of 55 VOGM probands, including 52 parent-offspring trios, revealed enrichment of rare damaging de novo mutations in chromatin modifier genes that play essential roles in brain and vascular development. Other VOGM probands harbored rare inherited damaging mutations in Ephrin signaling genes, including a genome-wide significant mutation burden in EPHB4. Inherited mutations showed incomplete penetrance and variable expressivity, with mutation carriers often exhibiting cutaneous vascular abnormalities, suggesting a two-hit mechanism. The identified mutations collectively account for ∼30% of studied VOGM cases. These findings provide insight into disease biology and may have clinical implications for risk assessment.Entities:
Keywords: EPHB4; Vein of Galen malformation; arterio-venous malformation; chromatin modifier; de novo mutations; ephrin signaling; pediatric neurosurgery; whole exome sequencing
Mesh:
Substances:
Year: 2018 PMID: 30578106 DOI: 10.1016/j.neuron.2018.11.041
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173